SLC2A13 and CYP4F2

  • Number of citations of the paper that reports this interaction (PubMedID 32296183)
  • 86
  • Data Source:
  • BioGRID (two hybrid)

SLC2A13

CYP4F2

Description solute carrier family 2 member 13 cytochrome P450 family 4 subfamily F member 2
Image No pdb structure No pdb structure
GO Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
  • Acenocoumarol maintenance dosage ( 19578179)
  • Alanine aminotransferase levels ( 34315874)
  • Aspartate aminotransferase levels ( 33547301 34315874)
  • Circulating phylloquinone levels ( 25411281)
  • Metabolite levels ( 23281178)
  • Response to Vitamin E supplementation ( 22437554)
  • Serum metabolite levels ( 33031748)
  • Urinary metabolite levels in chronic kidney disease ( 31959995)
  • Urinary metabolite modules (eigenmetabolites) in chronic kidney disease ( 31959995)
  • Vitamin E levels ( 21729881)
  • Warfarin maintenance dose ( 20833655 19300499)
Interacting Genes 5 interacting genes: ANO6 CYP4F2 FXYD6-FXYD2 PLP2 RIC8A 37 interacting genes: - AQP6 CHMP2A CPLX4 CREB3 CREB3L1 DNAJC1 EBP ELOVL4 ERGIC3 FAM210B FCER1G GJA8 HSD17B13 JAGN1 LEPROTL1 MMD MTIF3 MUC1 PGRMC2 PLEKHO1 REEP2 REEP4 RETREG3 SCN3B SDHAF2 SLC10A6 SLC17A8 SLC19A3 SLC2A13 THAP4 TLCD4 TM4SF19 TMEM51 TMEM82 TMX2 UBE2I
Entrez ID 114134 8529
HPRD ID 15363 05112
Ensembl ID ENSG00000151229 ENSG00000186115
Uniprot IDs Q96QE2 P78329
PDB IDs
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?